Vildax M 850 – Vildagliptin & Metformin Hydrochloride Tablets – 1 × 10 Tablets

Vildax-M 850 Tablets offer a premium, clinically integrated combination therapy carefully engineered for the management of Type 2 Diabetes Mellitus in adult patients. By uniting two distinct antidiabetic classes with complementary mechanisms of action into a single daily unit, this formulation significantly optimizes blood glucose control, enhances pancreatic hormone balance, and reduces overall pill burden.

The first active component, Vildagliptin (50 mg), belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It functions by blocking the degradation of incretin hormones, such as glucagon-like peptide-1 (GLP-1). This prolongs incretin activity, prompting the pancreatic beta cells to secrete insulin in a glucose-dependent manner while simultaneously suppressing inappropriate glucagon secretion from alpha cells. The second component, Metformin Hydrochloride (850 mg), is a biguanide that addresses insulin resistance. It acts primarily by decreasing hepatic glucose production (gluconeogenesis), delaying intestinal glucose absorption, and increasing peripheral glucose uptake and utilization by enhancing muscle sensitivity to insulin. Together, Vildax-M 850 works dynamically across multiple physiological fronts to deliver smooth stabilization of HbA1c baselines without inducing significant risks of sudden low blood sugar (hypoglycemia) or weight gain.

Key Benefits

• Synergistic Blood Sugar Control: Couples an advanced incretin enhancer with a fluid-clearing insulin sensitizer for superior antidiabetic efficacy.

• Dual Mechanism Action: Simultaneously limits glucose production in the liver and optimizes insulin responses to food intake.

• Fights HbA1c Surges: Maintains smooth, uninterrupted control over fasting and post-meal glucose parameters to keep therapeutic trends stable.

• Protects Vital Organs: Keeping high blood sugar balanced shields the kidneys, retinas, nervous system, and cardiovascular networks from progressive diabetic injury.

• Trusted Quality: Manufactured under the strict pharmaceutical quality benchmarks of Daxia Healthcare to ensure absolute dosing uniformity.

Directions for Use

• Take exactly as directed by your endocrinologist or primary physician.

• Swallow the tablet whole with a full glass of water. Do not crush, break, or chew it.

• Vildax-M 850 must strictly be taken with or immediately after a main meal (such as breakfast or dinner) to minimize potential initial gastrointestinal side effects like stomach upset or nausea, which are common to metformin configurations.

• Take your doses at the exact same times every single day to ensure consistent glycemic tracking parameters.

Safety & Precautions

• Do not stop taking this medication suddenly. Abruptly halting antidiabetic therapy can cause blood glucose levels to spike sharply, leading to severe metabolic imbalances.

• This medication is indicated exclusively for Type 2 Diabetes; it is not suitable for treating Type 1 Diabetes or diabetic ketoacidosis.

• Risk of Lactic Acidosis: Metformin can rarely cause a serious condition called lactic acidosis, particularly in patients with severe kidney or liver impairment. Inform your specialist if you experience deep, rapid breathing, muscle cramps, severe fatigue, or unexplained stomach pain.

• Periodic monitoring of kidney function tests (KFT), liver enzymes (LFT), and HbA1c levels is highly recommended during long-term care.

• Inform your doctor prior to undergoing any surgical procedures or radiological scans involving iodinated contrast dyes, as temporary adjustment of medication lines may be required.

• Keep out of reach of children.

Storage

• Store in a cool, dry place below 30°C.

• Protect from direct sunlight, excessive heat, and environmental room moisture.

• Keep the tablets safely stored inside their original protective packaging configuration until the time of consumption.